DK0938900T3 - Midler til forebyggelse/behandling af stomatitis - Google Patents

Midler til forebyggelse/behandling af stomatitis

Info

Publication number
DK0938900T3
DK0938900T3 DK97928459T DK97928459T DK0938900T3 DK 0938900 T3 DK0938900 T3 DK 0938900T3 DK 97928459 T DK97928459 T DK 97928459T DK 97928459 T DK97928459 T DK 97928459T DK 0938900 T3 DK0938900 T3 DK 0938900T3
Authority
DK
Denmark
Prior art keywords
stomatitis
prevention
treatment
zinc
remeties
Prior art date
Application number
DK97928459T
Other languages
Danish (da)
English (en)
Inventor
Masaaki Hirano
Shiro Katayama
Original Assignee
Zeria Pharm Co Ltd
Hamari Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeria Pharm Co Ltd, Hamari Chemicals Ltd filed Critical Zeria Pharm Co Ltd
Application granted granted Critical
Publication of DK0938900T3 publication Critical patent/DK0938900T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Preparations (AREA)
  • Materials For Medical Uses (AREA)
DK97928459T 1996-07-03 1997-06-25 Midler til forebyggelse/behandling af stomatitis DK0938900T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19164096A JP3877807B2 (ja) 1996-07-03 1996-07-03 口内炎治療・予防剤

Publications (1)

Publication Number Publication Date
DK0938900T3 true DK0938900T3 (da) 2006-09-04

Family

ID=16278026

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97928459T DK0938900T3 (da) 1996-07-03 1997-06-25 Midler til forebyggelse/behandling af stomatitis

Country Status (11)

Country Link
US (1) US6169083B1 (fr)
EP (1) EP0938900B1 (fr)
JP (1) JP3877807B2 (fr)
KR (1) KR20000022204A (fr)
AT (1) ATE326232T1 (fr)
AU (1) AU713337B2 (fr)
DE (1) DE69735892T2 (fr)
DK (1) DK0938900T3 (fr)
ES (1) ES2264166T3 (fr)
PT (1) PT938900E (fr)
WO (1) WO1998001146A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010025027A1 (en) * 2000-03-07 2001-09-27 Sonis Stephen T. Inhibition of ceramide for the prevention and treatment of oral mucositis induced by antineoplastic drugs or radiation
EP1285660A4 (fr) * 2000-05-31 2003-07-09 Hamari Chemicals Ltd Compositions d'apport complementaire de zinc destinees a une administration par voie orale
TWI280136B (en) * 2003-05-30 2007-05-01 Lytone Enterprise Inc Composition containing dipeptide of histidine and alanine for reducing uric acid
US20090142735A1 (en) * 2005-03-11 2009-06-04 Toyohiko Takushige Bacterial intraoral disease treatment composition, washing treatment solution, hemostatic treatment solution, and bacterial intraoral disease treatment method
JP5205618B2 (ja) * 2007-06-19 2013-06-05 学校法人日本大学 抗菌剤
JP2009235053A (ja) * 2008-03-05 2009-10-15 Kyowa Chem Ind Co Ltd 口内炎予防乃至治療薬
WO2016057910A1 (fr) * 2014-10-09 2016-04-14 Di Rocco Richard J Formulations de zinc +l-carnosine et procédés d'utilisation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6028921A (ja) * 1983-07-27 1985-02-14 Kaneshiro Nagai 炎症治癒促進剤
JPS61186322A (ja) * 1985-02-13 1986-08-20 Nippon Univ 免疾調節剤
JPS6314728A (ja) * 1986-07-03 1988-01-21 Zeria Shinyaku Kogyo Kk 肝障害の予防、治療剤
JPS63229058A (ja) 1987-03-17 1988-09-22 大鳥　泰雅 骨形成材料の製法
JPH07116160B2 (ja) * 1987-08-10 1995-12-13 浜理薬品工業株式会社 結晶性ｌ−カルノシン亜鉛錯体およびその製造法
JPH07500580A (ja) * 1991-09-09 1995-01-19 ペプテック　リミテッド 糖尿病の合併症及び病因の処理方法
US5380530A (en) 1992-12-29 1995-01-10 Whitehill Oral Technologies Oral care composition coated gum
FR2701948B1 (fr) * 1993-02-22 1996-07-26 Exsymol Sa Produit de couplage de l'histamine ou l'histamine méthyl-substituée et d'un acide aminé, procédé de préparation et applications thérapeutiques, cosmétologiques et agroalimentaires.
AUPN784796A0 (en) * 1996-02-02 1996-02-22 Bellara Medical Products Limited Supplementation of glucocorticoids

Also Published As

Publication number Publication date
ATE326232T1 (de) 2006-06-15
ES2264166T3 (es) 2006-12-16
JP3877807B2 (ja) 2007-02-07
US6169083B1 (en) 2001-01-02
AU3274597A (en) 1998-02-02
EP0938900A1 (fr) 1999-09-01
AU713337B2 (en) 1999-12-02
EP0938900B1 (fr) 2006-05-17
KR20000022204A (ko) 2000-04-25
WO1998001146A1 (fr) 1998-01-15
JPH1017490A (ja) 1998-01-20
DE69735892D1 (de) 2006-06-22
EP0938900A4 (fr) 2004-03-31
DE69735892T2 (de) 2006-09-28
PT938900E (pt) 2006-07-31

Similar Documents

Publication Publication Date Title
DK0572437T3 (da) 2,4-diaminoquinazolinderivater til forøgelse af antitumorvirkning
GB2368796A (en) Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
EA200100369A1 (ru) Химиотерапия рака с помощью ацетилдиналина в комбинации с гемцитабином, кэйпцитабином или цис-платиной
IL147017A0 (en) TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES
NO20014560L (no) Quinasoliner og terapautisk anvendelse derav
ATE306281T1 (de) Antivirales mittel in kombination mit strahlentherapie zur verwendung in der behandlung von krebs
MX9707022A (es) Derivados de fenilo trisustituidos.
PL322732A1 (en) Pharmaceutic agent containing n-chlorophenyl carbaminates and n-chlorophenyl thiocarbaminates for inhibiting development of viruses and carcinoma
IL97055A0 (en) Pharmaceutical compositions for sensitizing tumor cells comprising quinazolinedione derivatives
BR9814419A (pt) "combinação de compostos de benzociclo-heptapiridina e drogas antineopláticas para tratamento de doenças proliferativas"
DK0938900T3 (da) Midler til forebyggelse/behandling af stomatitis
DK0971710T3 (da) Anvendelse af chelerythrin og stråling til tumorterapi
FI934565A (fi) Pyrimidinderivat foer att oeka antitumoeraktiviteten
ATE285247T1 (de) Krebstherapie mit lymphotoxin
NO953349L (no) Kombinasjonsterapi av human cancer med cisplatin/tamoxifen
MD798G2 (ro) Metoda de tratament a cancerului mamar
CA2259997A1 (fr) Medicaments pour la prevention/le traitement de la stomatite
MX9200725A (es) Tratamiento de cancer esofagico. tratamiento de cancer esofagico.
IL164356A (en) Use of alpha- bromo or alpha-chloro acryloyl distamycin derivatives in the preparation of medicaments for treating cancer
EP0139005A4 (fr) Composition antitumorale, procede de traitement des tumeurs et utilisation de la composition pour le traitement des tumeurs.
ATE102832T1 (de) Regionale chemotherapie mit 4hydroperoxycyclophosphamid.
AU6514299A (en) Methods for the treatment of cancer using cytokines in combination with low level doses of chemotherapy and/or radiotherapy
ITMI980179A1 (it) Proteine ricombinanti derivate da hgf e msp
DE58904510D1 (de) Optisch reines dexniguldipin und dessen derivate zur behandlung von tumorerkrankungen.
WO2001073056A3 (fr) Regulation de l'enzyme humaine analogue a oxoprolinase